CETA introduction sees patent term extension launch in Canada

Innovators in Canada can now enjoy patent term extension for the first time as the Comprehensive Economic and Trade Agreement (CETA) between the EU and Canada entered into force provisionally today.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Canadian generics group hits out at trade deal

9 October 2018 The IP concessions in the United States-Mexico-Canada Agreement are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association.

Americas

Canada’s Senate passes Bill on pharma patent changes

16 May 2017 The Senate of Canada has passed Bill C-30, which will change Canada’s pharma patent regulations including by allowing patent owners to recover patent term lost due to regulatory delays.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

CETA introduction sees patent term extension launch in Canada

More on this story

Editor's picks

Editor's picks

More features